top of page
  • Writer's pictureColin

Workshop on Novel Clinical Trial Methodologies [PMX Africa]

Innovative drug development methods and tools are developed and used by pharmaceutical industry, clinical research organisations, public/private partnerships, and academic researchers to decrease cost and time to market and to increase the probability of success of pharmaceuticals R&D. Novel clinical trial methodologies based on stringent scientific criteria have gained acceptance for successful regulatory approval. The US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have established formal advice procedures for qualification of such methodologies, in consultation with the scientific community.

This workshop was presented by Fundisa African Academy of Medicines Development and Pharmacometrics Africa to provide insights into the use of modelling and simulation, adaptive trial designs and real-world effectiveness studies by local and international experts with hands-on experience. Over 50 delegates from academia, industry, regulatory agencies and ethics committees attended this interactive forum of presentations and discussions.

Agenda and Links to Presentations:

Meeting Host and Opening Remarks: Bernd Rosenkranz

Modeling and Simulation (Chair: Phumla Sinxadi)

Clinical Trial Designs (Chair: Colin Pillai)

Presentation Materials

The detailed agenda and all presentation materials are available for download from the Fundisa Academy website or by following the hyperlinks above.

For enquiries, please contact

Recent Posts

See All

Second Applied Pharmacometrics Training program underway

The Applied Pharmacometrics Training (APT) program in Africa is comprised of a 3-month virtual program that provides fellows with training to conduct regulatory-quality pharmacometrics analyses and re


bottom of page